Basics Fortress Biotech, Inc. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products. IPO Date: December 1, 2011 Sector: Healthcare Industry: Biotech Market Cap: $54.41M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 3.65% Avg Daily Range (30 D): $0.05 | 2.63% Avg Daily Range (90 D): $0.04 | 2.54% Institutional Daily Volume Avg Daily Volume: .41M Avg Daily Volume (30 D): .15M Avg Daily Volume (90 D): .23M Trade Size Avg Trade Size (Sh.): 228 Avg Trade Size (Sh.) (30 D): 248 Avg Trade Size (Sh.) (90 D): 222 Institutional Trades Total Inst.Trades: 36 Avg Inst. Trade: $2.41M Avg Inst. Trade (30 D): $1.09M Avg Inst. Trade (90 D): $1.09M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.49M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 11.5K     News May 30, 2025 @ 2:47 PM Fortress Biotech Announces Closing of Sale of Subs... Source: Globe Newswire May 7, 2025 @ 12:00 PM Fortress Biotech to Participate in the H.C. Wainwr... Source: N/A Feb 10, 2025 @ 1:00 PM Mustang Bio Announces Closing of $8 Million Public... Source: N/A Feb 6, 2025 @ 12:00 PM Mustang Bio Announces Pricing of $8 Million Public... Source: Globe Newswire Feb 6, 2025 @ 12:00 PM Mustang Bio Announces Pricing of $8 Million Public... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.23 $-.48 $-.26 Diluted EPS $-2.23 $-.48 $-.26 Revenue $ 57.78M $ 13.14M $ 15.12M Gross Profit $ 38.93M $ 8.35M $ 12.88M Net Income / Loss $ -106.52M $ -24.69M $ -26.32M Operating Income / Loss $ -96.04M $ -22.32M $ -23.84M Cost of Revenue $ 18.85M $ 4.79M $ 2.24M Net Cash Flow $ 9.19M $ 33.74M $ -24.55M PE Ratio     Splits Oct 10, 2023:   1:15 Dec 06, 2022:   1:10